Wednesday, April 3, 2013

Drug shortages spur debate over role of compounding pharmacies

By Jaimy Lee
Posted: April 3, 2013 - 3:15 pm ET

Persistent drug shortages have led healthcare providers, pharmacists and others to debate the role of compounding pharmacies as alternative sources of drugs in short supply.

In a letter released April 2, the National Community Pharmacists Association urged the Food and Drug Administration to “preserve the role” of compounders in providing access to scarce drugs.

The advocacy group Public Citizen took the opposite stance, arguing that allowing patients to use those drugs puts them at a safety risk. The group also said compounders can exacerbate drug shortages by creating more competition for the few manufacturers that produce the generic sterile injectable drugs that have made up the majority of drug shortages.

“Under no circumstances should the FDA rely on unregistered facilities, such as companies manufacturing drugs under the guise of pharmacy compounding, to supply the market with unapproved products in times of shortage,” the group said in a comment letter.


Read more: Drug shortages spur debate over role of compounding pharmacies | Modern Healthcare http://www.modernhealthcare.com/article/20130403/NEWS/304039965#ixzz2PSqOmDv1
?trk=tynt 

No comments: